Fluanxol



Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 34.7%
Product Used For Unknown Indication 27.8%
Schizophrenia 8.6%
Drug Exposure During Pregnancy 6.1%
Depression 4.1%
Rheumatoid Arthritis 4.1%
Delusion 2.4%
Schizophrenia, Paranoid Type 2.0%
Anxiety 1.6%
Mental Disorder 1.6%
Abdominal Pain 0.8%
Antiviral Prophylaxis 0.8%
Extrapyramidal Disorder 0.8%
Obsessive-compulsive Disorder 0.8%
Personality Disorder 0.8%
Prophylaxis Against Hiv Infection 0.8%
Thyroid Disorder 0.8%
Akathisia 0.4%
Alcoholism 0.4%
Breast Cancer 0.4%
Myopathy 23.4%
Visual Impairment 10.4%
Drug Interaction 7.8%
Urinary Retention 6.5%
Mental Disorder 5.2%
Posture Abnormal 5.2%
Schizophrenia, Paranoid Type 5.2%
Death 3.9%
Fallot's Tetralogy 3.9%
Tachycardia 3.9%
Vomiting 3.9%
Galactorrhoea 2.6%
Hallucination, Auditory 2.6%
Hypokalaemia 2.6%
Muscle Disorder 2.6%
Renal Failure Acute 2.6%
Sudden Death 2.6%
Suicide Attempt 2.6%
Atrioventricular Block 1.3%
Cardiac Arrest 1.3%
Concomitant
Schizophrenia 15.5%
Product Used For Unknown Indication 12.8%
Depression 11.2%
Schizophrenia, Paranoid Type 9.7%
Anxiety 6.7%
Insomnia 5.5%
Pain 5.5%
Sedative Therapy 3.6%
Anti-infective Therapy 2.7%
Breast Cancer 2.7%
Drug Use For Unknown Indication 2.7%
Hypertension 2.7%
Supplementation Therapy 2.7%
Bipolar Disorder 2.4%
Borderline Personality Disorder 2.4%
Schizoaffective Disorder 2.4%
Antidepressant Therapy 2.1%
Coagulopathy 2.1%
Psychotic Disorder 2.1%
Small Cell Lung Cancer Metastatic 2.1%
Weight Increased 13.0%
Vertigo 7.8%
Acute Respiratory Distress Syndrome 6.5%
Psychotic Disorder 6.5%
Neutropenia 5.2%
Sedation 5.2%
Suicide Attempt 5.2%
Tremor 5.2%
Urinary Tract Infection 5.2%
Aggression 3.9%
Galactorrhoea 3.9%
Hyperglycaemia 3.9%
Hypotension 3.9%
Pancreatic Carcinoma 3.9%
Suicidal Ideation 3.9%
Transaminases Increased 3.9%
Visual Impairment 3.9%
Vomiting 3.9%
Anticholinergic Syndrome 2.6%
Antipsychotic Drug Level Increased 2.6%
Interacting
Drug Use For Unknown Indication 100.0%
Erectile Dysfunction 40.0%
Drug Interaction 20.0%
Hospitalisation 20.0%
Orthostatic Hypotension 20.0%